Free Trial

This company has been marked as potentially delisted and may not be actively trading.

Chimerix (CMRX) News Today

Chimerix logo

CMRX Latest News

Chimerix reports Q4 EPS (25c), consensus (28c)
CMRX Stock Surges on JAZZ Acquisition Bid
Chimerix downgraded to Hold from Buy at JonesResearch
Chimerix downgraded to Neutral from Outperform at Wedbush
North Carolina drugmaker sold in $935M deal
Chimerix downgraded to Neutral from Buy at H.C. Wainwright
Chimerix stock rises on FDA priority review for dordaviprone
Chimerix’s NDA for dordaviprone accepted by FDA
Chimerix to Speak Today at The White House Cancer Moonshot Forum
Small Cap Soars On FDA Submission Plans
TD Cowen Reaffirms Their Buy Rating on Chimerix (CMRX)
Chimerix to submit dordaviprone NDA to FDA, seeks accelerated approval
Get Chimerix News Delivered to You Automatically

Sign up to receive the latest news and ratings for CMRX and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

CMRX Media Mentions By Week

CMRX Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

CMRX
News Sentiment

0.00

0.44

Average
Medical
News Sentiment

CMRX News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

CMRX Articles
This Week

0

0

CMRX Articles
Average Week

Get the Latest News and Ratings for CMRX and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Chimerix and its competitors.

Sign Up
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

Related Companies and Tools


This page (NASDAQ:CMRX) was last updated on 5/9/2026 by MarketBeat.com Staff.
From Our Partners